Employee Benefits News examines legal developments that impact the employee benefits and executive compensation employers provide, including federal and state legislation, rules from federal...
Blue Shield of California is free from a lawsuit challenging its failure to cover hepatitis C drug Harvoni as a federal judge dismissed patients’ claims against the insurer ( Homampour v. Blue Shield of Cal. Life & Health Ins. Co. , 2016 BL 428020, N.D. Cal., No. 3:15-cv-05003-WHO, 12/22/16 ).
The lawsuit challenged certain limitations Blue Shield placed on Harvoni coverage before 2015, when it amended its criteria and later invited patients who had been denied coverage for the drug to reapply. This move rendered the patients’ lawsuit moot, the judge found on Dec. 22, because it represented a broad policy shift that made it “unlikely” that the challenged practices would reoccur.
In the past year, Anthem Blue Cross Life and Health Insurance Co., Blue Cross and Blue Shield of Florida Inc. and United Healthcare Services Inc. have settled similar lawsuits by agreeing to cover Harvoni with fewer restrictions. Related claims are pending against Health Care Service Corp. and BlueCross BlueShield of Illinois.
The judge hearing the case against Blue Shield of California first granted the insurer’s motion to dismiss in August, but he allowed the patients an opportunity to restate their claims. In his latest ruling, the judge found that Blue Shield’s decision to remove coverage restrictions for Harvoni rendered most of the lawsuit moot.
The judge also found that the patients had no valid claim against Blue Shield Life because none of them had shown that they were participants in a Blue Shield Life-insured health plan. He similarly rejected the idea that the two Blue Shield companies should be treated as a single entity.
Judge William H. Orrick of the U.S. District Court for the Northern District of California wrote the opinion.
Kantor & Kantor LLP represented the patients. Manatt Phelps & Phillips LLP represented Blue Shield.
To contact the reporter on this story: Jacklyn Wille in Washington at email@example.com
To contact the editor responsible for this story: Jo-el J. Meyer at firstname.lastname@example.org
Text of the decision is at http://www.bloomberglaw.com/public/document/Homampour_v_Shield_No_15cv05003WHO_2016_BL_428020_ND_Cal_Dec_22_2.
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)